Search Results for: Syndrome

October 11, 2019October 11, 2019

BAP1 Syndrome – Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.

Melanoma Literature

Publication date: Aug 15, 2019 BAP1 syndrome is an autosomal dominant hereditary cancer syndrome associated with increased risk of malignant mesothelioma; uveal and cutaneous melanoma; kidney cancer; lung adenocarcinoma; meningioma; ... Read more

October 7, 2019October 7, 2019

Lofexidine May Effectively Mitigate Symptoms of Opioid Withdrawal Syndrome

Opioids News

Publication date: Oct 07, 2019 Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome (OWS) compared with placebo, according to research presented at Psych Congress ... Read more

October 5, 2019October 5, 2019

Nomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force.

Parkinson's Disease Literature

Publication date: Oct 04, 2019 Genetically determined myoclonus disorders are a result of a large number of genes. They have wide clinical variation and no systematic nomenclature. With next-generation sequencing, ... Read more

October 3, 2019October 3, 2019

Behcet’s-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy.

Melanoma Literature

Publication date: Oct 01, 2019 The landscape for the treatment of metastatic melanoma has been revolutionized with the introduction immune checkpoint inhibitors. Immune checkpoint inhibitors have now become the standard ... Read more

October 3, 2019October 3, 2019

Behcet’s-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy.

Melanoma Literature

October 1, 2019October 1, 2019

Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes.

Opioids Literature

Publication date: Oct 01, 2019 Pain can have a devastating effect on the quality of life of patients in palliative medicine. Thus far, majority of research has been centered on ... Read more

September 27, 2019September 27, 2019

CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome

Opioids News

Publication date: Sep 26, 2019 A Phase II, multicenter, double blind, double dummy, randomized, 2 arms parallel study to evaluate the efficacy, safety and pharmacokinetics of CHF6563 in babies with ... Read more

September 20, 2019September 20, 2019

Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis.

Precision Medicine Literature

Publication date: Sep 18, 2019 Traditional statistical models allow population based inferences and comparisons. Machine learning (ML) explores datasets to develop algorithms that do not assume linear relationships between variables ... Read more

September 13, 2019September 13, 2019

State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.

Opioids Literature

Publication date: Sep 13, 2019 Since 1999, the rate of opioid use disorder (OUD) has more than quadrupled, from 1.5 per 1,000 delivery hospitalizations to 6.5 (1), with similar increases ... Read more

September 7, 2019September 7, 2019

Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature.

Melanoma Literature

Publication date: Sep 05, 2019 Autoimmune polyendocrine syndrome type II (APS-2) is a rare constellation of autoimmune hypoadrenalism, thyroid dysfunction and/or type 1 diabetes (T1DM), usually occurring in the 3rd ... Read more